Major depressive symptoms in breast cancer patients with ovarian function suppression: a cross-sectional study comparing ovarian ablation and gonadotropin-releasing hormone agonists.
Junhan JiangJunnan XuLi CaiLi ManLimin NiuJuan HuTao SunXinyu ZhengPublished in: BMC psychiatry (2021)
This is the first study to demonstrate that GnRHa results in more favorable depressive symptoms outcomes than OA. Moreover, most patients preferred alternatives to their OFS treatment. These findings can contribute to improving and alleviating the adverse effects of OFS.
Keyphrases
- depressive symptoms
- end stage renal disease
- ejection fraction
- social support
- newly diagnosed
- physical activity
- prognostic factors
- peritoneal dialysis
- type diabetes
- metabolic syndrome
- adipose tissue
- patient reported outcomes
- combination therapy
- atrial fibrillation
- radiofrequency ablation
- replacement therapy
- glycemic control